These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2826851)

  • 1. [Differences in changes of two serum markers of hepatic fibrogenesis in acute hepatitis].
    Matsuda Y; Yasuhara M; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Aug; 84(8):1631-8. PubMed ID: 2826851
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of malotilate treatment on the serum markers of hepatic fibrogenesis in liver cirrhosis.
    Takase S; Takada A; Yasuhara M; Sato H; Matsuda Y
    Gastroenterol Jpn; 1988 Dec; 23(6):639-45. PubMed ID: 2851477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum 7S collagen in various liver diseases.
    Yamada S; Suou T; Kawasaki H; Yoshikawa N
    Clin Biochem; 1992 Dec; 25(6):467-70. PubMed ID: 1335851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic fibrosis and its serum markers].
    Okabe K
    Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis.
    Fabris C; Falleti E; Federico E; Toniutto P; Pirisi M
    Ann Clin Biochem; 1997 Mar; 34 ( Pt 2)():151-5. PubMed ID: 9133247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procollagen Type III-N-terminal peptide as an indicator of hepatic fibrogenesis].
    Sajewicz Z; Poniewierka E
    Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):325-6. PubMed ID: 2235718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY; Chu CM; Sheen IS; Liaw YF
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.
    Torres-Salinas M; Parés A; Caballería J; Jiménez W; Heredia D; Bruguera M; Rodés J
    Gastroenterology; 1986 May; 90(5 Pt 1):1241-6. PubMed ID: 3007261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
    Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
    Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical markers of hepatic fibrosis.
    Plebani M; Burlina A
    Clin Biochem; 1991 Jun; 24(3):219-39. PubMed ID: 1651819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assay of serum collagen markers in chronic liver diseases and liver cancer].
    Inoue T; Funaki N; Hatahara T; Igarashi S; Kaneko E; Tanaka H
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1506-13. PubMed ID: 2170716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis.
    Gabrielli GB; Capra F; Casaril M; Squarzoni S; Tognella P; Dagradi R; De Maria E; Colombari R; Corrocher R; De Sandre G
    Clin Chim Acta; 1997 Sep; 265(1):21-31. PubMed ID: 9352126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
    Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
    Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amino-terminal procollagen type-III peptide and hepatic fibrogenesis].
    Castilla Cortázar A
    Med Clin (Barc); 1993 Mar; 100(11):436. PubMed ID: 8464262
    [No Abstract]   [Full Text] [Related]  

  • 17. Type III procollagen peptide and PZ-peptidase serum levels in pre-cirrhotic liver diseases.
    Morelli A; Vedovelli A; Fiorucci S; Angelini GP; Fini C; Palmerini CA; Floridi A
    Clin Chim Acta; 1985 May; 148(2):87-95. PubMed ID: 3888456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseases.
    Müller A; Krombholz B; Pott G; Machnik G; Vollandt R; Reinhardt M; Jorke D
    Clin Chim Acta; 1991 Feb; 197(1):59-66. PubMed ID: 1646085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases.
    Chang TT; Lin HC; Lee SD; Tsai YT; Lee FY; Jeng FS; Wu JC; Yeh PS; Lo KJ
    Scand J Gastroenterol; 1989 Jun; 24(5):533-8. PubMed ID: 2762752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
    Kürkçüoğlu N; Oz G
    J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.